EPILEPSY RESEARCH INSTITUTE UK

Registered charity 1100394 · accounts filings on the Charity Commission register · Wikidata: Q5382978 · Wikipedia · also known as EPILEPSY RESEARCH FOUNDATION, EPILEPSY RESEARCH UK, FUND FOR EPILEPSY

The Epilepsy Research Institute serves as the central hub for the epilepsy research community. The Institute aims to strengthen the epilepsy research ecosystem . Prior to becoming the Institute in 2023, it was Epilepsy Research UK which was formed by the merger of the Epilepsy Research Foundation and the Fund for Epilepsy in April 2007.

Objects

1. TO PROMOTE, ENCOURAGE AND FINANCE RESEARCH INTO EPILEPSY AND ASSOCIATE DISEASES AND THEIR UNDERLYING CAUSES;2. TO PROMOTE AND IMPROVE THE TREATMENT CARE AND WELFARE OF PERSONS AFFECTED FROM EPILEPSY AND ASSOCIATED DISEASES; AND 3. TO ADVANCE THE GENERAL EDUCATION AND UNDERSTANDING OF THE PUBLIC CONCERNING THE NATURE AND CAUSES OF EPILEPSY AND ASSOCIATED DISEASES AND THE TREATMENT THEREOF.

Area of benefit: NOT DEFINED. IN PRACTICE EUROPE

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Registered contact address: Southwark, London, England (from the postcode on the register)

Received the assets of:
Source: Charity Commission register of merged charities (OGL v3.0).
Latest income
£1.7m
Latest spending
£2.9m
Registered
2003
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that total incoming resources decreased to £1.7 million from £3.6 million in the prior year, primarily due to a significant drop in legacy income. Despite this reduction, the charity maintained its grant-giving levels, resulting in a net expenditure for the year and a decrease in total reserves from £4.2 million to £3.1 million. The Trustees remain confident in the charity's ability to continue as a going concern, citing sufficient liquidity and investment funds to meet current commitments.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Related-party transaction: Extension to co-funded award with Angelini Pharma of £199,913 made to Trustee Professor Mark Richardson as lead applicant. The whole amount was funded by Angelini Pharma with monetary contribution from the Institute.
“In 2025, there was an extension to a co-funded award with Angelini Pharma of £199k was made to Trustee Professor Mark Richardson as lead applicant. This was awarded via the Institute, but the whole amount was funded by Angelini Pharma with monetary contribution from the Institute.” — page 64
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Kreston Reeves LLP. Discloses 3 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/03/2025

  • Volunteers: 42
  • Employees paid over £60,000: 1 (£120,001–£130,000: 1)
  • Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for services to the charity; other trustee benefit
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/03/2024

  • Volunteers: 42
  • Government income: £1,478,851 — grants £1,478,851 (1); 41% of the £3,595,109 total gross income on the same return
  • Employees paid over £60,000: 2 (£70,001–£80,000: 1; £90,001–£100,000: 1)
  • Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for services to the charity
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/03/2023

  • Volunteers: 25
  • Government income: £1,451,840 — grants £1,451,840 (1); 40% of the £3,605,370 total gross income on the same return
  • Employees paid over £60,000: 1 (£80,001–£90,000: 1)
  • Grant-making is its main activity

Source: this charity’s annual returns on the Charity Commission register.

Annual return filing dates (Charity Commission record)

Of its last 5 annual returns with a recorded received date, 1 was received after the due date: year ending 31/03/2023 (received 02/12/2024, 306 days after the 31/01/2024 due date).

Due and received dates as recorded in the Commission’s annual-return data; the data does not say whether an extension was agreed. Source: this charity’s annual returns on the Charity Commission register.

Corporate structure

Public fundraising profile: JustGiving — Epilepsy Research Institute UK (matched by registered charity number).

Company officers (Companies House)

Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.

Official officers record.

Structured financials (annual return, FY ending 31/03/2025)

Total income
£1.7m
Total spending
£2.9m
Cost of raising funds
£269k
Reserves (reported)
£3.1m
Employees
14

Reported reserves equal ~12.9 months of spending — in the top quarter for charities its size (median 4.7 months; benchmarks).

Per its annual return, cost of raising funds: 15.8% of total income — above the median for charities its size (5.3%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025£1.7m£2.9m
31/03/2024£3.6m£3.1m
31/03/2023£3.6m£2.7m
31/03/2022£2.4m£2.3m
31/03/2021£1.2m£2.0m

Common questions

Is EPILEPSY RESEARCH INSTITUTE UK financially healthy?

Per its FY2025 accounts: The accounts state that total incoming resources decreased to £1.7 million from £3.6 million in the prior year, primarily due to a significant drop in legacy income. Despite this reduction, the charity maintained its grant-giving levels, resulting in a net expenditure for the year and a decrease in total reserves from £4.2 million to £3.1 million. The Trustees remain confident in the charity's ability to continue as a going concern, citing sufficient liquidity and investment funds to meet current commitments. Its FY2025 accounts were audited by Kreston Reeves LLP.

Who funds EPILEPSY RESEARCH INSTITUTE UK?

Funders whose own accounts filings name EPILEPSY RESEARCH INSTITUTE UK as a grant recipient include THE ALBERT GUBAY CHARITABLE FOUNDATION, ROBERT LUFF FOUNDATION LIMITED, THE IAN FLEMING CHARITABLE TRUST, THE TUBEROUS SCLEROSIS ASSOCIATION, BRITISH EPILEPSY ASSOCIATION.

Known funders

Grants to this charity found in funders’ own accounts filings.

FunderYearAmountPurpose (as stated by the funder)
THE ALBERT GUBAY CHARITABLE FOUNDATIONFY2022£80kGeneral Fund
THE ALBERT GUBAY CHARITABLE FOUNDATIONFY2023£80k
ROBERT LUFF FOUNDATION LIMITEDFY2025£60k
THE IAN FLEMING CHARITABLE TRUSTFY2026£40k
THE ALBERT GUBAY CHARITABLE FOUNDATIONFY2023£35k
THE TUBEROUS SCLEROSIS ASSOCIATIONFY2025£33kInvestigating new targets for TSC treatments
BRITISH EPILEPSY ASSOCIATIONFY2021£23kInstitutional grants
ROBERT LUFF FOUNDATION LIMITEDFY2023£20k
ROBERT LUFF FOUNDATION LIMITEDFY2024£10k
THE IAN FLEMING CHARITABLE TRUSTFY2025£10k
CECIL PILKINGTON CHARITABLE TRUSTFY2022£5k
CECIL PILKINGTON CHARITABLE TRUSTFY2024£5k
CECIL PILKINGTON CHARITABLE TRUSTFY2023£5k
THE JOHN R. MURRAY CHARITABLE TRUSTFY2023Unverified read£5kAdvancement of health and the saving of lives
SANDRA CHARITABLE TRUSTFY2023£4k
THE ANTHONY AND ELIZABETH MELLOWS CHARITABLE SETTLEMENTFY2022£4kThe advancement of health or saving of lives
CECIL PILKINGTON CHARITABLE TRUSTFY2025£3k
THE SANDHU CHARITABLE FOUNDATIONFY2023£3k
SIR SAMUEL SCOTT OF YEWS TRUSTFY2022£3k
THE SANDHU CHARITABLE FOUNDATIONFY2022£3k
C A REDFERN CHARITABLE FOUNDATIONFY2022£3k
SANDRA CHARITABLE TRUSTFY2022£3k
C A REDFERN CHARITABLE FOUNDATIONFY2021£3k
THE JOHN R. MURRAY CHARITABLE TRUSTFY2022Unverified read£2kAdvancement of health and the saving of lives
THE SAMUEL STOREY FAMILY CHARITABLE TRUSTFY2021£2k
THE IAN ASKEW CHARITABLE TRUSTFY2022£1kGrant
JOHN SWIRE 1989 CHARITABLE TRUSTFY2021£1k
JOHN SWIRE 1989 CHARITABLE TRUSTFY2023£1k
LILIAN FRANCES HIND BEQUEST (TRUSTEES OF LADY HIND)FY2022£1kMedical / Disabled
THE CHANDRIS FOUNDATIONFY2022£500Other Charities
THE CHANDRIS FOUNDATIONFY2021£500Other Charities
C A REDFERN CHARITABLE FOUNDATIONFY2025amount not stated
C A REDFERN CHARITABLE FOUNDATIONFY2023amount not stated

Grants marked “Unverified read” were flagged by automated checks as possibly misread from the funder’s filed accounts. They are listed, but left out of the totals, counts and funder relationships this site computes.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with EPILEPSY SOCIETY.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
EPILEPSY RESEARCH INSTITUTE UK£1.7m——unclear—no doubt
EPILEPSY SOCIETY FY2025£20.7m——unclear—no doubt
EPILEPSY OUTLOOK FY2025£92k—0below—no doubt
HOPE for Epilepsy FY2025£62k—0unclear—no doubt
INTERNATIONAL LEAGUE AGAINST EPILEPSY (BRITISH BRANCH) FY2025£331k—0above—no doubt
MEDICAL RESEARCH FOUNDATION FY2025£3.7m——unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.